Antonella Verrienti

Pubblicazioni

Titolo Pubblicato in Anno
Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance ENDOCRINE 2024
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer ENDOCRINE 2024
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2024
Excellent RAI therapeutic response on a patient presenting skull metastasis of follicular thyroid cancer after 15 years ENDOCRINE 2024
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency CELLS 2024
The role of miR-139-5p in radioiodine-resistant thyroid cancer JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance BIOMÉDECINE & PHARMACOTHÉRAPIE 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value BIOMARKER RESEARCH 2023
Establishment and maintenance of thyroid organoids from human cancer cells STAR PROTOCOLS 2022
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells BIOMEDICINES 2022
The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment ENDOCRINE 2022
The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations ENDOCRINE 2022
Precision oncology for RET-related tumors FRONTIERS IN ONCOLOGY 2022
Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation ENDOCRINE 2022
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells ENDOCRINE 2022
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility ENDOCRINE 2021
SEaCorAl: Identifying and contrasting the regulation-correlation bias in RNA-Seq paired expression data of patient groups COMPUTERS IN BIOLOGY AND MEDICINE 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside CLINICAL EPIGENETICS 2021
In silico drug repurposing in COVID-19. A network-based analysis BIOMÉDECINE & PHARMACOTHÉRAPIE 2021

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma